
Sign up to save your podcasts
Or
Visit pointofcaremedicine.com to see the templates, pearls, literature, and other resources discussed in this episode.
Our mission is to create accessible and easy-to-use digital resources that help healthcare professionals tackle common clinical presentations at the point of care, without getting bogged down by unnecessary details or trivia.
Time Stamps:
00:00:08 - Background and Definitions
00:01:39 - Pathophysiology
00:03:22 - Admission Checklist
00:04:25 - HPI Intake
00:05:51 - Physical Exam
00:06:06 - Differential Diagnosis
00:06:38 - Plan - Workup and Treatment
00:08:54 - If You Remember Nothing Else
00:10:14 - Pearls - Etiology
00:11:00 - Pearls - Presentation and Diagnosis
00:13:07 - Pearls - Treatment
00:15:20 - Literature and Trials
00:15:56 - Wrap Up
Show Notes:
Gout Review (NEJM, 2022)STOP Gout Trial (NEJM, 2022) - allopurinol non-inferior to febuxostat for preventing flares and for reaching target urate concentrations at 48 weeks
4.9
99 ratings
Visit pointofcaremedicine.com to see the templates, pearls, literature, and other resources discussed in this episode.
Our mission is to create accessible and easy-to-use digital resources that help healthcare professionals tackle common clinical presentations at the point of care, without getting bogged down by unnecessary details or trivia.
Time Stamps:
00:00:08 - Background and Definitions
00:01:39 - Pathophysiology
00:03:22 - Admission Checklist
00:04:25 - HPI Intake
00:05:51 - Physical Exam
00:06:06 - Differential Diagnosis
00:06:38 - Plan - Workup and Treatment
00:08:54 - If You Remember Nothing Else
00:10:14 - Pearls - Etiology
00:11:00 - Pearls - Presentation and Diagnosis
00:13:07 - Pearls - Treatment
00:15:20 - Literature and Trials
00:15:56 - Wrap Up
Show Notes:
Gout Review (NEJM, 2022)STOP Gout Trial (NEJM, 2022) - allopurinol non-inferior to febuxostat for preventing flares and for reaching target urate concentrations at 48 weeks
492 Listeners
691 Listeners
809 Listeners
3,325 Listeners
259 Listeners
1,220 Listeners
1,116 Listeners
191 Listeners
716 Listeners
513 Listeners
349 Listeners
248 Listeners
44 Listeners
237 Listeners
9 Listeners